Vera Therapeutics (VERA) Depreciation & Amortization (CF) (2023 - 2026)
Vera Therapeutics (VERA) posted Depreciation & Amortization (CF) of $140000.0 for Q1 2026, up 3.7% on a QoQ basis from $135000.0 in Q4 2025, and up 64.71% year-over-year from $85000.0 in Q1 2025.
Vera Therapeutics (VERA) Depreciation & Amortization (CF) (2023 - 2026) Analysis & Trends
Vera Therapeutics' Depreciation & Amortization (CF) history runs 4 years deep, the most recent figure standing at $140000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 64.71% year-over-year to $140000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $523000.0 (up 192.18% YoY) and the FY2025 annual result came in at $468000.0, up 345.71% from the prior year.
- Depreciation & Amortization (CF) was $140000.0 for Q1 2026 at Vera Therapeutics, up from $135000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $140000.0 in Q1 2026 and bottomed at $4000.0 in Q4 2023.
- A 4-year average of $65727.3 and a median of $55000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) jumped 1275.0% — and 2026, when it surged 64.71%.
- Vera Therapeutics' Depreciation & Amortization (CF) stood at $4000.0 in 2023, then soared by 1275.0% to $55000.0 in 2024, then surged by 145.45% to $135000.0 in 2025, then grew by 3.7% to $140000.0 in 2026.
- Business Quant data shows VERA's Depreciation & Amortization (CF) at $140000.0 in Q1 2026, $135000.0 in Q4 2025, and $129000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 140,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Dec 31, 2025 | 135,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Jun 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 15,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Mar 31, 2024 | 11,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |